Prolonged or Interrupted Research and Development Due to Changes in the Market, Technology and Regulations
First written in FY2016. 18 of 19 entries say "Restated". Latest entry: FY2025-H1.
The whole theme swung hardest in 2025: 3 of 22 companies on the "Worse" side.
44 other companies' latest entry also says "Restated".
- FY2025-H1RestatedAnnual report
「During the interim consolidated accounting period under review, there were no significant changes in the matters described in this interim report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
市場・技術・規制変化による研究開発の長期化・中断リスクについて、重要な変更はないと扱っている。 - FY2024-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
市場・技術・規制変化による研究開発の長期化・中断リスクについて、重要な変更はないと扱っている。 - FY2024-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
市場・技術・規制変化による研究開発の長期化・中断リスクについて、重要な変更はないと扱っている。 - FY2023-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
市場・技術・規制変化による研究開発の長期化・中断リスクについて、重要な変更はないと扱っている。 - FY2023-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
市場・技術・規制変化による研究開発の長期化・中断リスクについて、重要な変更はないと扱っている。 - FY2023-Q1RestatedAnnual report
「During the first quarter of the current consolidated cumulative period, there were no occurrences of matters that could materially affect investors’ investment decisions among the matters relating to the business and financial position described in this quarterly report, nor were there any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
市場・技術・規制変化による研究開発の長期化・中断リスクについて、重要な変更はないと扱っている。 - FY2022RestatedAnnual report
「・開発の進捗状況のチェック ・開発テーマの定期的な見直し」
製品・技術開発の遅延・中止リスクに対し、進捗確認と開発テーマの定期見直しを対策として明示した。 - FY2021RestatedAnnual report
「当社グループでは、開発の意思決定後も、計画の進捗状況を定期的に検証し、必要に応じて計画を見直すなどしながら開発を進めております。」
市場変化・技術革新等による新製品開発の延期・断念リスクと、進捗検証・計画見直しによる対応を記載している。 - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
市場・技術・規制変化による研究開発の長期化・中断リスクについて、重要な変更はないと扱っている。 - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
市場・技術・規制変化による研究開発の長期化・中断リスクについて、重要な変更はないと扱っている。 - FY2021-Q1RestatedAnnual report
「During the first quarter of the current consolidated cumulative period, there were no occurrences of matters that could materially affect investors’ investment decisions among the matters relating to the business and financial position described in this quarterly report, nor were there any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
市場・技術・規制変化による研究開発の長期化・中断リスクについて、重要な変更はないと扱っている。 - FY2020-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
市場・技術・規制変化による研究開発の長期化・中断リスクについて重要な変更はないと扱っている。 - FY2018-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
市場・技術・規制変化による研究開発の長期化・中断リスクについて重要な変更がないと扱っている。 - FY2018-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
市場・技術・規制変化による研究開発の長期化・中断リスクについて重要な変更はないと扱っている。 - FY2017RestatedAnnual report
「①予期せざる市場、技術、法令規制等の変化により研究開発が長期化又は中断する可能性がある。②将来の市場や顧客のニーズ等を正しく予想できず新製品や既存製品をタイムリーに開発・提供できない可能性がある。」
市場・技術・規制変化および顧客ニーズ予測の不確実性による研究開発リスクを再確認している。 - FY2017-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
市場・技術・規制変化による研究開発の長期化・中断リスクについて重要な変更はないと扱っている。 - FY2017-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
市場・技術・規制変化による研究開発の長期化・中断リスクについて重要な変更はないと扱っている。 - FY2017-Q1RestatedAnnual report
「During the first quarter of the current consolidated cumulative period, there were no occurrences of matters that could materially affect investors’ investment decisions among the matters relating to the business and financial position described in this quarterly report, nor were there any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
市場・技術・規制変化による研究開発の長期化・中断リスクについて重要な変更がないと扱っている。 - FY2016First statedAnnual report
「予期せざる市場、技術、法令規制等の変化により研究開発が長期化又は中断する可能性がある。」
市場・技術・法令規制の変化と、顧客ニーズ予測の不確実性を研究開発リスクとしている。